Patient: Page 17
-
Advocacy Cheerleader — Barby Ingle
I have been battling chronic pain since 1997. First with endometriosis, which resulted in a full hysterectomy and left oophorectomy. Then in 2002, I developed Reflex Sympathetic Dystrophy (RSD), which is also known as Central Pain Syndrome. This is a progressive neuro-autoimmune condition that af...
By Barby Ingle • March 1, 2021 -
The Patient Knows Best
The patient voice is crucial throughout the entire healthcare process, but especially relevant in creating spot-on patient education. Shantana Hazel, Wayne Eskridge, and Lisa Lurie are just three of thousands of patient activists who have used their own patient journey and experiences to create i...
By Robin Robinson • March 1, 2021 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
Education is Key — Daniel Garza
I remember being at Ben Taub Hospital in Houston. Texas. September 2000, I think it was Tuesday the 26th. I had been in the hospital over the weekend, weighed about 110 lbs. with a T-cell count of 108, and the diagnosis was AIDS. I had been in an isolated room, with only my mother, father, and si...
By Daniel Garza • March 1, 2021 -
A Family Affair — Estela Lugo
I wish I could say there was a time in my life when I felt “normal," but there really isn’t. Some of my first memories include sitting on the number rug in kindergarten and showing off my new plastic leg braces to friends. It was 1984 when doctors at Nassau County Medical Center in New York broke...
By Estela Lugo • March 1, 2021 -
Decentralized Clinical Trials: The Way Forward
COVID-19 prompted the need for the industry to address patient needs in the clinical trial space, and companies along the drug development paradigm pivoted successfully to the benefit of patients. Necessity is the mother of invention, and over the past 12 to 18 months because of the limitations n...
By Taren Grom • March 1, 2021 -
Becoming a Patient Partner — Claire Snyman
May 14, 2010. I woke up to the room spinning. That day is forever etched in my mind. Firstly, because of the unfamiliar, sickening vertigo that rippled through my body, rendering me helpless. Secondly, because this symptom led to a cascade of events that four days later landed me in the ER diagno...
By Calire Snyman • March 1, 2021 -
Patient Heroes
Patient heroes have the power to positively change the status quo because of their influence, knowledge, passion, and commitment to improving the patient journey. The global patient engagement solutions market size is expected to reach $70.5 billion by 2028, according to a new report by Grand Vie...
By PharmaVoice Team • March 1, 2021 -
Advocate For Changes That Protect Patients — Molly Stallings
My mission is to create the best patient experience possible — from product development through program execution, each department plays a unique role in contributing to a patient’s overall experience. The consumerization of healthcare combined with the disruptive power of mobile technology prese...
By Molly Stallings • March 1, 2021 -
Mission: Disrupt Health Disparities — Dr. Altovise Ewing
I envision a future of healthcare where genetics is used to advance health equity. I deem this a critical and possible mission, and believe our work at Genentech is a step in the right direction to getting us there. Dr. Altovise Ewing’s passion for health equity is personal. As a Black woman rais...
By Altovise T. Ewing • March 1, 2021 -
20 Years in the Making: Special Section
From day one our goal has been to convene a community of experts who would be committed to our mission of: read, think, and participate. And you have. PharmaVOICE is proud to celebrate the contributions of thousands of thought leaders and subject matter experts who have lent their insights on a w...
By PharmaVoice Team • March 1, 2021 -
Commanders & Chiefs: Chief Patient Officers
More and more companies are elevating patient-facing roles to the C-Suite, as a result, these key roles continue to expand and evolve to address the goals of patient-centricity and patient engagement. Dr. Julie Gerberding Merck Respecting Voices Across the Spectrum of Advocacy The concept of pati...
By PharmaVoice Team • March 1, 2021 -
Fulfilling a Great Promise
Analysts attribute the continued growth of the cell and gene therapy (CGT) market to steady investment and consolidation in cell and gene therapies, with 16 out of the 20 largest biopharma companies adding CGT products to their portfolios. In the recent past, cell and gene therapies have emerged ...
By PharmaVoice Team • Feb. 1, 2021 -
Innovator's Journey
Every entrepreneur’s path is unique, yet they share some core characteristics. They are willing to take calculated risks, they are visionary, they are fearless, and they are always thinking about the next big thing. The statistics are somewhat sobering: 20% of new companies fail in thei...
By PharmaVoice Team • Jan. 1, 2021 -
How AI Can Improve Understanding of Patient's Behavior and Symptoms
Running and managing clinical trials, at the most basic level, is about creating a foundation to get the best possible data. While a great deal of thought goes into recruiting the right patients and developing the most effective protocols, initiatives designed to improve the experience for the pa...
By Michelle Marlborough • Oct. 1, 2020 -
SHOWCASE: Patient Solutions: The Changing Face of Patient Engagement
Digital technologies are changing the healthcare landscape, creating opportunities for patient-support programs, patient monitoring and self-management. There is massive demand for patient-engagement solutions, with predictions that the market for such solutions will reach $30.36 billion by 2026....
By PharmaVoice Team • Oct. 1, 2020 -
Advancing Beyond the Traditional Patient Adherence Model
Delivering value in the era of empowered patients renders the one-size-fits-all patient services program obsolete. Not every treatment journey is consistently linear within a disease state because patients take different paths to medication adherence. For example, one patient may be compliant whe...
By Maria Kirsch • Oct. 1, 2020 -
Social Connection Is Possible in a Time of Physical Distancing
In this time of physical distancing, technology often seems like the go-to solution for helping people connect. However, data linking social media and depression, as well as research pointing to social divisiveness online, might give us pause. Recent survey results found most Americans believe th...
By Amrita Bhowmick • Oct. 1, 2020 -
Listening to the Patient for Better Outcomes
The aim of drug development is to improve patient outcomes. Historically, clinical research has been driven by researchers, with little or no input from patients, contributing to many of the challenges and inefficiencies we see in today’s clinical trials. Some of these challenges include low enro...
By Gretchen Goller • Oct. 1, 2020 -
Speak Out: The Power of Virtual Patient Simulation in CME
Simulation as we think of it today has been used in medical education since the 18th century,1 and has continued to evolve into realistic and medically accurate physical and digital solutions designed to allow learners to simulate a scenario-based encounter with a patient in a safe environment. V...
By Martin Warters • Oct. 1, 2020 -
Accessible Healthcare: The Key Role of Health Literacy
Health literacy can have a significant bearing on outcomes, so helping patients understand their health and treatments is critical. Health information is by its very nature complex. Explaining a disease or how to take a drug or a drug’s potential side effects to a patient can be difficult and can...
By Kim Ribbink • Sept. 1, 2020 -
Mentors
These champions of diversity and inclusion are dedicated to developing the next generation of leaders and setting an example for others to follow. An Ally for All Raising the bar… by bringing people together Peter Anastasiou Title: Executive VP & Head of North America Company: Lundbeck Indust...
By PharmaVoice Team • Aug. 1, 2020 -
Patient Access: Keeping the Channel Open During a Crisis
A managed access program enables pharmaceutical and biotechnology companies to make certain investigational or unapproved treatments available to eligible patients through their prescribing physicians. But what happens when the supply chain is disrupted by a pandemic, such as COVID-19? The worldw...
By Carolyn Gretton • May 1, 2020 -
Commanders & Chiefs
The role of chief technology officer has become more encompassing as companies adopt new software and technology-based solutions to solve some of their biggest challenges and create opportunities for new rewards. Zaher El-Assi Decentralizing & Accelerating Trials Next-generation innovations t...
By PharmaVoice Team • May 1, 2020 -
Upfront
BMS Undergoes Brand Transformation Bristol Myers Squibb has revealed a new brand to reflect its evolution in light of its acquisition of Celgene for $74 billion late last year. The changes reflect an updated website, logo, and a change in punctuation — removing the hyphen between Bristol and Myer...
By PharmaVoice Team • April 1, 2020 -
HealthTech
Boehringer-Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox Trend Watch: HealthTech Innovations Continue to Transform Patient Care Boehringer Ingelheim and Carebox Healthcare Solutions have launched MyStudyWindow, a digital platform empowering patients, families, caregivers, an...
By PharmaVoice Team • April 1, 2020